Document:

EXHIBIT 10.12

                           SOFTWARE LICENSE AGREEMENT
                             AGREEMENT NO. A0035730

This Software License Agreement ("Agreement") is between TurboWorx, Inc.
("Licensee"), with a place of business at 3 Enterprise Drive, Shelton,
Connecticut 06484, and International Business Machines Corporation ("IBM"), a
New York corporation, through its Almaden Research Center, located at 650 Harry
Road, San Jose, CA 95120.

         WHEREAS, IBM has developed TSpaces software, a set of network
communication buffers that allow heterogeneous, Java-enabled devices to exchange
data; and

         WHEREAS, Licensee wishes to obtain a license to the source code for the
TSpaces software for incorporation into its product offerings and distribution
as object code therein; and

         WHEREAS, IBM is willing to license TSpaces software to Licensee,
subject to the terms and conditions of this Agreement;

         NOW, THEREFORE, for good and valuable consideration as stated herein,
IBM and Licensee agree as follows:

1.0      DEFINITIONS

1.1      "Agreement" means this Software License Agreement.

1.2      "Customer" means an Enterprise using or licensing Offerings distributed
         by Licensee, its Subsidiaries, and/or its or their authorized
         distributors, dealers or remarketers.

1.3      "Effective Date" means the date upon which this Agreement has been
         signed by both parties.

1.4      "Enterprise" is a legal entity (such as a corporation) and its
         Subsidiaries.

1.5      "Licensed Software" means the documents and software, including source
         code, listed in Appendix A and provided to Licensee pursuant to Article
         2.0 of this Agreement..

1.6      "Net Revenue" means, with respect to any particular calendar quarter,
         the invoice price, the license fee, or any other charge for an Offering
         to a Customer after any applicable discounts or promotions, without any
         deductions except for special packing costs, freight, warehousing,
         transit insurance and duties, which may be excluded if such items are
         separately stated in the invoice. The Net Revenue for an Offering
         transferred to a Customer or other party without cash consideration,
         excluding Offerings transferred as prototypes, engineering samples or
         qualification units, will be deemed to be the average invoice price of
         an Offering sold or licensed to a Customer over the previous three

                                       1
<PAGE>

         months, or in the absence of such transactions, the fair market value
         of the Offering to a Customer.

1.7      "Offering" means any product, software or service offering designed
         and/or produced by or on behalf of Licensee utilizing or incorporating
         the Licensed Software or any part thereof, or any derivative thereof,
         or which interacts with any or all of the Licensed Software using the
         APIs of the Licensed Software, which is offered for sale or for
         license, or otherwise marketed or transferred by Licensee, or its
         Subsidiaries.

1.8      "Subsidiary" means a corporation, company or other entity:

                  i. more than 50% of whose outstanding shares or securities
         (representing the right to vote for the election of directors or other
         managing authority) are now or hereafter owned or controlled, directly
         or indirectly, by a party hereto, but such corporation, company or
         other entity will be deemed to be a Subsidiary only so long as such
         ownership or control exists; or

                  ii. which does not have outstanding shares or securities, as
         may be the case in a partnership, joint venture or unincorporated
         association, but more than 50% of whose ownership interest representing
         the right to make the decisions for such corporation, company or other
         entity is now or hereafter owned or controlled, directly or indirectly
         by a party hereto, but such corporation, company or other entity will
         be deemed to be a Subsidiary only so long as such ownership or control
         exists.

2.0      INTELLECTUAL PROPERTY AND RIGHTS THEREUNDER

2.1      Subject to the terms of this Agreement, IBM grants to Licensee a
         nonexclusive, worldwide copyright license, to prepare derivative works
         of and to use, execute, reproduce, display, modify and perform the
         source code for the Licensed Software within Licensee and its
         Enterprise only, for the sole purpose of integrating the Licensed
         Software into Offerings. Licensee will own the derivative works it
         creates, subject to IBM's ownership of the Licensed Software as
         delivered hereunder.

2.2      Subject to the terms of this Agreement, IBM grants to Licensee a
         nonexclusive, worldwide, royalty bearing copyright license to
         distribute copies of the object code of the Licensed Software only as
         part of Offerings to Licensee Customers, either directly or through
         Licensee Subsidiaries, authorized distributors, dealers or remarketers.

2.3      Subject to the terms of this Agreement, IBM grants to Licensee a
         nonexclusive, worldwide, fully paid up copyright license to use,
         reproduce and execute the object code of the Licensed Software: (a)
         within Licensee's enterprise for purposes of providing maintenance
         services related to the Offerings to Licensee's customers, and (b) to
         distribute copies of the object code of the Licensed Software, under
         terms consistent with the license granted in this Section 2.3, only to
         third parties providing development or other services related to the
         Offerings to the Licensee, provided, however, that such third

                                       2
<PAGE>

         parties shall not use the Licensed Software for any production or
         commercial purposes, or otherwise as a Customer.

2.4      The Licensed Software is licensed, not sold. IBM does not transfer
         title to the copyright in the Licensed Software. Except as expressly
         permitted herein, Licensee will not rent, lease, assign or otherwise
         transfer the Licensed Software.

2.5      Licensee's Offering will be licensed under Licensee's end user license
         agreement. Upon IBM's request, Licensee will provide IBM with the form
         of Licensee's agreements used to license the Licensed Software as part
         of Offerings. Licensee will obtain the Customer's agreement to
         Licensee's license agreements that include, at a minimum, the
         following: (a) authorization to make only one copy of the Offerings for
         backup or archival purposes only; (b) prohibition from any other
         copying or transferring of the Offering; (c) direction to destroy all
         copies of the Offering, other than the one archival copy, within three
         months after license termination; (d) prohibition from reverse
         assembling, reverse compiling or translating the Offering except as
         permitted by law without Licensee waiving this term of the license
         agreement; (e) statements that: the Offering is copyrighted and
         licensed; it is not sold; the end user license agreement does not pass
         title to the Offering; (f) terms consistent with Article 8.2 of this
         Agreement; and (g) the following provision: "Software provided under
         this Agreement may contain or be derived from portions of code provided
         by third parties under license to Licensee. Customer agrees that its
         sole remedy under any cause of action shall be from Licensee and not
         any such third party." Licensee will provide for any potential Customer
         of Licensee's Offering the opportunity to review the terms of the
         license for the Offering prior to installation. Licensee will ensure
         that trademarks, copyrights and other notices included in Licensed
         Software continue to appear when the Customer runs the Licensed
         Software in the Offering.

2.6      IBM will ship or make available to Licensee the Licensed Software
         listed in Appendix A, along with an itemized list of the contents of
         such Licensed Software and its basic functions, no later than six weeks
         after the Effective Date of the Agreement, unless otherwise mutually
         agreed upon by the parties.

2.7      Licensee shall imbed or incorporate the Licensed Software in the
         Offering. Licensee shall not offer for sale, license, or otherwise
         distribute the Licensed Software unless and until imbedded or
         incorporated into an Offering, and any such sale or distribution shall
         be a material breach of this Agreement.

2.8      It is understood and agreed that IBM retains sole title and ownership
         of the Licensed Software and all intellectual property rights related
         thereto.

3.0      TECHNICAL COORDINATORS

         Andrew Sherman, for Licensee, and Toby Lehman, for IBM, are the
         Technical Coordinators for this Agreement. Each Technical Coordinator
         will be responsible for

                                       3
<PAGE>

         exchanging information with the other party, coordinating the delivery
         of the Licensed Software, and arranging all other matters pertinent to
         this Agreement. Either party may change its Technical Coordinator by
         giving written notice to the other party. The parties agree that the
         Technical Coordinators will meet by phone monthly for one hour, or as
         otherwise mutually agreed upon, so that IBM may apprise Licensee of
         upcoming releases, bug fixes or other significant information, if any,
         regarding the Licensed Software.

4.0      TECHNICAL ASSISTANCE AND CONSULTING

4.1      For the period beginning on the Effective Date of this Agreement and
         ending on December 31, 2004 and for each 12 month period thereafter,
         IBM will provide to Licensee up to ten (10) hours of Level III
         technical assistance or consultation. Level III support provides
         commercially reasonable efforts to isolate logical errors in the code
         and deliver correction or circumvention (or notice that no correction
         or circumvention is available). Level III support may be requested of
         the designated IBM contact(s) via email or phone during regular
         business hours only and by no more than two designated contact persons
         on the Licensee staff. Each company's Technical Coordinator will
         designate contact persons(s) for requesting and providing technical
         assistance. Either party may change its contact person(s) upon prior
         written notice to the other party.

         Licensee may request to purchase additional Level III support in 10
         hour blocks at the rate of $2,000 for each 10 hour block. Upon IBM's
         agreement to provide such additional amounts of Level III support, IBM
         will invoice Licensee, and Licensee shall pay such invoice within 30
         days of receipt. IBM will have no obligation to provide such additional
         Level III support until such invoice is paid in full. Fees for Level
         III Support do not apply toward guaranteed minimum royalties on
         Offerings incorporating Licensed Software. Licensee is also responsible
         for payment of IBM's reasonable travel and living expenses in the event
         IBM agrees to provide the technical assistance or consultation at a
         location other than the IBM Almaden Research Center.

4.2      Subject to the limitations of the agreed upon Level III support
         commitment, IBM and Licensee agree that it is in the best interests of
         both parties for Licensee to use in its Offerings the current version
         of the Licensed Software, and the Technical Coordinators shall work
         together to facilitate Licensee's incorporation of appropriate updates,
         modifications, error corrections, or enhancements into its Offerings.
         Notwithstanding the forgoing, IBM shall have no obligation to update,
         modify, enhance, or add to the Licensed Software, or to deliver to
         Licensee any such updates, modifications or enhancements to Licensee in
         the event such are made.

4.3      As agreed upon by the Technical Coordinators, but no less frequently
         than quarterly, Licensee shall provide to IBM in source code format any
         error corrections ("Error Corrections") that Licensee develops for the
         Licensed Software, either as a result of Licensee's own initiative or
         based on technical consultations with IBM. Subject to the terms of this
         Agreement, Licensee grants to IBM a nonexclusive, worldwide copyright
         license, to prepare derivative works of and to use, execute, reproduce,
         display, modify,

                                       4
<PAGE>

         perform and distribute, and to sublicense others to the same rights as
         those granted to IBM hereunder, the source code and/or the object code
         for the Error Corrections without limitation. Licensee shall provide
         IBM with a certificate of originality or the equivalent for each Error
         Correction provided to IBM.

5.0      CONSIDERATION

5.1      Subject to the terms and conditions of this Section 5.0, Licensee shall
         pay IBM a royalty of 3% (three percent) of Net Revenue for any sale,
         license or other transfer of an Offering, or any Licensee-developed
         derivative thereof. Notwithstanding such royalty payment obligation,
         for each Calendar Quarter during which this Agreement is in effect,
         beginning on or after January 1, 2004, Licensee shall pay IBM, , a
         nonrefundable minimum royalty in the amount specified in the table
         below.

         Year        Amount Payable each
                     Quarter as a Minimum
                     Quarterly Royalty

         2004         $7,500
         2005        $10,000
         2006        $12,500
         2007        $15,000
         2008        $17,500

         The following shall contribute toward Licensee's minimum quarterly
         royalty payment obligation: (i) payment of any royalties due for any
         sale, license, or other transfer of an Offering to a Customer, (ii) for
         any sale, license or other transfer of an Offering to a Customer
         incurring $50,000 or more in aggregate actual or potential payment
         obligations to Licensee as part of any single transaction or multiple
         related transactions (aggregate payment obligations includes payments
         from all sources, including but not limited to products, services or
         maintenance), Licensee shall pay IBM a nonrefundable minimum royalty of
         $1,500, and (iii) in the event that the total amount due IBM under (i)
         and (ii) above for a quarter does not equal or exceed the Licensee's
         minimum quarterly payment obligation, Licensee shall pay IBM the
         difference.

         For each Customer, the balance, if any, of the minimum amount paid
         under (ii) above that exceeds the actual royalty due IBM (a "Royalty
         Credit Balance") will be applied until exhausted toward Licensee's
         future royalty payment obligations for such Customer only. Any future
         royalty payments due IBM that are deducted from a Customer's Royalty
         Credit Balance shall not apply toward Licensee's ongoing minimum
         quarterly royalty payment obligation.

         For example, for a Customer transaction in which Licensee pays IBM the
         $1,500 minimum under (ii) above, if the actual royalty due IBM for such
         transaction is $500, the

                                       5
<PAGE>

         $1,000 balance paid will be treated as a Royalty Credit Balance to be
         applied against royalties due IBM from subsequent sales to the same
         Customer. After the Royalty Credit Balance is exhausted in this manner,
         Licensee would pay IBM the standard royalty on all sales, licenses or
         transfers of the Offering.

5.2      An Offering is considered "sold" when billed or invoiced by Licensee,
         or its Subsidiaries or thirty (30) days from the date of delivery,
         whichever is earlier. An Offering is considered "licensed" when a
         license is entered into between Licensee, or its Subsidiaries and a
         licensee or thirty (30) days from the date of delivery, whichever is
         earlier. An Offering is considered "otherwise transferred" when not
         sold or licensed, but delivered by Licensee or its Subsidiaries to
         others, or used for its and/or its Subsidiaries' internal production,
         use or consumption.

5.3      All royalties and other payments will be paid in US Dollars. All
         royalties will be due and payable within thirty (30) days after the end
         of each Calendar Quarter, beginning with the first Calendar Quarter of
         2004. Licensee will provide to IBM, within thirty (30) days after the
         conclusion of each Calendar Quarter, a written quarterly report of all
         royalty payments due IBM for the previous Calendar Quarter. The
         quarterly report shall be in a format to be defined and mutually agreed
         upon by the parties, and will include at a minimum a summary for the
         Calendar Quarter of the number of Offerings sold, licensed, or
         otherwise transferred by Licensee, and the calculation of the total
         payments owed IBM. Such royalty report shall be reviewed and certified
         as accuracy and completeness by Andrew Sherman, Vice President of
         Operations and Chief Technical Officer of Licensee, or another officer
         of Licensee as mutually agreed upon by the parties in writing. The
         consideration set forth in this Article 5 does not include the payment
         of fees for technical assistance and consultation due pursuant to
         Article 4.1 above or amounts due IBM as reimbursement for reasonable
         travel and living expenses.

5.4      "Calendar Quarter" will mean the consecutive three month periods ending
         on March 31, June 30, September 30, and December 31.

5.5      Payments due under Articles 5.1, and 5.2 will be sent by electronic
         funds transfer to:

                  IBM Director of Licensing
                  The Bank of New York
                  1 Wall Street
                  New York, NY 10286
                  Credit Account No. 890-0209-674
                  ABA No. 0210-0001-8

         Reports will be sent by mail to:

                  IBM Director of Licensing
                  Intellectual Property & Licensing
                  International Business Machines Corporation

                                       6
<PAGE>

                  North Castle Drive, MD - NC119
                  Armonk, New York 10504-1785

                  with a copy to:

                  Almaden Research Center
                  International Business Machines Corporation
                  650 Harry Road

                  San Jose, CA 95120
                  Attn.: Business Relations

5.6      A License Reference Number will be assigned to this Agreement by IBM
         upon execution of the Agreement. This number must be included in all
         communications, including wire transfer payments, royalty reports, tax
         credit certificates, letters, faxes and e-mail messages pertaining to
         the payments made pursuant to Articles 5.1 and 5.2.

5.7      In order that the payments and reports required by this Agreement may
         be verified, Licensee will keep detailed records which determine
         payment(s) due to IBM under this Agreement for a period of at least six
         (6) years after the Calendar Quarter in which such Offerings were sold,
         licensed, or otherwise transferred.

5.8      Upon IBM's request, but no more frequently than annually (unless in
         response to a dispute), Licensee will permit an independent accounting
         firm chosen by IBM to have access upon reasonable prior notice at
         Licensee's offices during normal business hours to such Licensee
         records and information as may be necessary to determine the
         correctness of any report or payment made or due under this Agreement.
         Licensee will provide its full cooperation in such an audit.

         If an audit should disclose any underpayment of payments due IBM,
         Licensee will, within thirty (30) days after notice of such
         underpayment, pay IBM such amount, together with a late payment fee
         calculated in accordance with Article 5.9 below. The cost of the audit
         will be at IBM's expense, except if the audit reveals an underpayment
         greater than Ten Thousand Dollars ($10,000), in which case Licensee
         will pay IBM's reasonable expenses related to the audit.

         In addition, IBM may, at any time during the term for payment of
         royalties under Article 5.0, request that Licensee investigate
         identified Offerings being sold or otherwise transferred by or on
         behalf of Licensee without royalty payments to IBM, to determine
         whether royalties are due IBM pursuant to Article 5.0. Licensee agrees
         to investigate in good faith, provide a report to IBM of the results of
         the investigation, and pay royalties on such Offerings within 90 days
         of the request to investigate if Licensee's investigation reveals that
         royalties are payable under Article 5.0.

5.9      IBM will be entitled to late payment fees on payments due but not
         received within thirty (30) days after the due date. Late payment fees
         are defined as the lesser of one percent

                                       7
<PAGE>

         (1%) of the amount due, compounded each subsequent thirty (30) day
         period that payments remain unpaid, or the highest rate permitted by
         law.

5.10     Licensee will bear and pay all taxes (including, but not limited to,
         sales, property and value added taxes) imposed by any governmental
         entity of any country in which Licensee is doing business, except that
         Licensee will not be liable for any taxes based on IBM's net income.
         Taxes paid by Licensee will not be deducted from or credited against
         payments due IBM.

6.0      TERM AND TERMINATION

6.1      The term of this Agreement ("Term") will commence on the Effective Date
         and will expire on December 31, 2008.

6.2      If any default of this Agreement occurs, and such default is not cured
         within thirty (30) days after written notice from the non-defaulting
         party, the non-defaulting party shall have the right to terminate this
         Agreement by giving written notice of termination to the defaulting
         party, which termination shall be effective thirty (30) days after
         receipt of such written notice of termination.

6.3      IBM may terminate this Agreement if Licensee becomes insolvent, is
         dissolved or liquidated, has a petition in bankruptcy, reorganization,
         dissolution or liquidation, or similar action filed by or against it,
         is adjudicated a bankrupt, has a receiver appointed for its business,
         or makes an assignment for the benefit of creditors.

6.4      Upon the termination of this Agreement under this Article 6.0, the
         licenses granted to Licensee under Article 2.0 above shall terminate,
         and Licensee shall make no further use of, nor sell, license or
         otherwise transfer, the Licensed Software, provided, however, that
         after any termination except for Licensee's default, Licensee may
         continue to collect recurring license fees from Customers that licensed
         Offerings under a term license while the Agreement was in effect, and
         shall pay IBM royalties arising therefrom until such term licenses
         expire or are terminated. Upon termination, Licensee agrees to return
         all copies of the Licensed Software or destroy the Licensed Software
         then in its possession and certify its destruction no later than five
         (5) days after the termination date specified in the termination
         notice. Licensee's payment obligations under Article 5.0 shall survive
         any termination of this Agreement.

6.5      Either party may terminate this Agreement at any time by notifying the
         other party upon sixty (60) days prior written notice. Licensee's
         payment obligation under Article 5.0 shall survive any termination of
         this Agreement, and Licensee shall pay IBM the Minimum Quarterly
         Royalty payment, as provided in Section 5.1, for the Calendar Quarter
         in which such termination is effective.

6.6      Notwithstanding any other provision of this Agreement, any licenses
         granted to Customers in or to any Offering prior to termination of this
         Agreement shall not be

                                       8
<PAGE>

         affected by such termination, but shall survive the termination of this
         Agreement and remain in effect in accordance with its terms.

7.0      CONFIDENTIALITY

7.1      "IBM Confidential Information" means the Licensed Software, in both
         source and object code form, provided to Licensee by IBM pursuant to
         this Agreement. "Licensee Confidential Information" means all Licensee
         quarterly royalty reports furnished under this Agreement, and the
         identity of Licensee's Customers.

7.2      Subject to Section 7.3 below, IBM Confidential Information and Licensee
         Confidential Information will be kept confidential under the terms of
         Confidential Disclosure Agreement ("CDA"), No. 3554 between IBM and
         Licensee as modified by Supplement 1 thereto. The parties agree that
         this Section 7.2 extends the term of the CDA, as provided in Supplement
         1, to be consistent with the term of this Agreement.

7.3      Notwithstanding the terms of the CDA, IBM source code will be held
         confidential by Licensee for a period of seven (7) years from the
         original expiration date of this Agreement, whether or not terminated
         earlier for any reason, and Licensee agrees to use IBM source code only
         for purposes of this Agreement or otherwise for the benefit of IBM.

7.4      Nothing herein shall be construed to prevent a party from seeking or
         obtaining injunctive relief against the actual or threatened disclosure
         by the other party of its Confidential Information.

8.0      WARRANTY, REPRESENTATIONS, DISCLAIMER, INDEMNIFICATION AND LIMITATION
         OF LIABILITY

8.1      IBM warrants that it has the right to grant the licenses granted in
         Article 2.0.

8.2      EXCEPT AS PROVIDED IN ARTICLE 8.1, THE LICENSED SOFTWARE ANY OTHER
         DELIVERABLES, AND ANY SERVICES PROVIDED UNDER THIS AGREEMENT ARE
         PROVIDED "AS IS", AND IBM MAKES NO WARRANTY, EXPRESS OR IMPLIED,
         INCLUDING, WITHOUT LIMITATION, THE IMPLIED WARRANTIES OF
         MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE UNDER THIS
         AGREEMENT.

         IBM DOES NOT REPRESENT OR WARRANT:

         (i) that Licensee will successfully produce Offerings using or based on
         the Licensed Software;

         (ii) that the Licensed Software provided under this Agreement will meet
         the requirements of Licensee, its Subsidiaries, or its or their
         distributors, dealers, or remarketers, or any of its or their
         Customers; or

                                       9
<PAGE>

         (iii) that the Licensed Software or any other items provided under this
         Agreement do not infringe any third party patents or any other
         intellectual property right.

8.3      Licensee will, at Licensee's expense, defend, indemnify and hold
         harmless IBM, its Subsidiaries, and its and their officers, directors,
         agents, representatives and employees from and against any and all
         claims, demands, damages, liabilities, penalties, and expenses,
         including, but not limited to, reasonable attorney's fees and costs,
         whether arising in contract, tort or otherwise, wherever and by
         whomever brought, arising out of, in connection with a claim brought
         against IBM by any third party (other than an IBM Subsidiary),
         resulting from (i) Licensee's modification of the Licensed Software or
         integration of the Licensed Software into Offerings; (ii) distribution
         or licensing of Offerings, either alone or in combination with other
         Licensee offerings, or (iii) Licensee's breach of this Agreement. Such
         obligation to defend, indemnify and hold harmless is subject to and
         conditioned on: (i) IBM promptly notifying Licensee in writing of such
         claim, demand, damage, liability, penalty or expense; (ii) IBM
         cooperating with Licensee, at Licensee's expense, in the defense of the
         claim, as may be reasonably requested by Licensee; and (iii) Licensee
         having full control over the defense (including selection and
         management of counsel) and any monetary settlement of the matter;
         provided however, IBM may participate in any such defense at its own
         expense. IBM's consent is required for any non monetary settlement or
         other resolution of the matter which may materially and adversely
         affect IBM.

8.4      If an infringement claim is threatened or actually made with respect to
         the Licensed Software, IBM may (at its option) replace the Licensed
         Software with a software program that is at least functionally
         equivalent. If IBM determines that such a software program is not
         reasonably available, Licensee agrees to return any copies of the
         Licensed Software and IBM will have the right to terminate the
         Agreement.

8.5      Except for either party's breach of Article 7.0, Licensee's breach of
         Article 2, and the costs of indemnification under Article 8.3, each
         party's cumulative liability for damages to the other party under this
         Agreement, for any cause whatsoever, regardless of form or action,
         shall be limited to US$100,000. The foregoing does not apply to any
         payment obligation due and owing under this Agreement.

8.6      Except for breach of Article 2.0 and 7.0, and for any costs of
         indemnification under Article 8.3, neither party shall be liable to the
         other for indirect, incidental or consequential damages arising out of
         or caused by the performance or nonperformance of this Agreement, the
         breach of its terms and conditions, or the termination of this
         Agreement. In addition, IBM shall not be liable for any claim by
         Licensee based on any third party claim (except as specifically set
         forth in Article 8.4).

9.0    GENERAL PROVISIONS

                                       10
<PAGE>

9.1      This Agreement does not confer any rights to use in advertising,
         publicity or other marketing activities any name, trade name,
         trademark, or other designation of either party hereto, including any
         contraction, abbreviation, or simulation of any of the foregoing
         without prior written agreement.

9.2      All notices, other than those related to payments under Article 5.0
         (which will be governed by the notice requirements in Article 5.0),
         will be in writing and will be valid and sufficient if sent by: (1)
         registered or certified mail, return receipt requested, postage
         prepaid; (2) by facsimile (provided the receipt of the facsimile is
         evidenced by a printed record of completion of transmission); or (3) by
         express mail or courier service providing a receipt of delivery.
         Notices will be effective upon receipt. Notices will be addressed to
         the parties at the following addresses:

         To IBM:

         Almaden Research Center
         International Business Machines Corporation
         650 Harry Road
         San Jose, CA 95120
         Attn.: Business Relations

         To Licensee:

         Turboworx, Inc.
         3 Enterprise Drive
         Shelton, Connecticut 06484
         Attn: Andrew Sherman

         Either party may change its address by a notice given to the other
         party in the manner set forth above.

9.3      Neither party will be liable for any failure or delay in the
         performance of its obligations under this Agreement if such failure or
         delay is due to acts of God, acts of the other party, fire, flood,
         natural catastrophe, acts of any government or of any civil or military
         authority, national emergencies, riots, war, insurrection, strikes, or
         any occurrence beyond the reasonable control of such party.

9.4      Each party agrees to comply and to reasonably assist the other in
         complying with applicable U.S. federal, state and local laws,
         regulations and ordinances as they apply to this Agreement, including,
         without limitation, those laws and regulations of the U.S. Department
         of Commerce relating to the export or re-export of technical data or
         commodities.

                                       11
<PAGE>

9.5      Except as specifically set forth in this Agreement, no license is
         granted or implied, either directly or indirectly, by implication or
         estoppel or otherwise, to either party under any patent, copyright or
         other intellectual property right of the other party.

9.6      Licensee may not assign, delegate or otherwise transfer this Agreement
         or its rights or obligations hereunder without the prior written
         consent of IBM. Notwithstanding the foregoing, Licensee may assign this
         Agreement in connection with the merger of Licensee with another party,
         the acquisition of Licensee by another party, or the sale of all or
         substantially all of the assets of Licensee to another party, provided
         that (a) the acquiring party is not involved in a dispute with IBM
         related to intellectual property rights of any kind, and (b) the
         acquiring party shall agree in writing to assume and be bound by all of
         Licensee's obligations under this Agreement (c) prior written notice of
         such assignment is provided to IBM. ANY ASSIGNMENT OTHER THAN AS
         EXPRESSLY PROVIDED IN THIS SECTION 9.6 IS VOID.

9.7      Except for claims arising out of Articles 5.0, 7.0 or 8.3, neither
         party may bring an action, regardless of form, arising out of the
         performance of this Agreement more than one year after the cause of
         action has accrued.

9.8      This Agreement will not be construed to establish any form of
         partnership, agency, franchise or joint venture of any kind between
         Licensee and IBM, nor to constitute either party as the agent,
         employee, legal representative, or any other form of representative of
         the other.

9.9      Each party acknowledges that it has not relied on any promises,
         inducements, representations or other statements made by the other
         party regarding the commercial viability, profitability or success in
         the marketplace of any Offerings, and that each party's decision to
         enter into this Agreement is made independently from the other party.

9.10     Each party represents that it has, or will have, in place appropriate
         agreements with its employees or others whose services the party may
         require, sufficient to enable such party to comply with all the
         provisions of this Agreement.

9.11     Nothing in this Agreement will be construed to limit the right of
         either party, alone or with others, to design, develop, make, procure,
         market and/or maintain offerings, now or in the future, which may
         constitute competitive alternatives to the Licensed Software.

9.12     If any provision of this Agreement is held to be invalid, illegal or
         unenforceable, the validity, legality and enforceability of the
         remaining provisions will in no way be affected or impaired thereby so
         long as the intent of the parties can be preserved.

9.13     This Agreement is governed by the laws of the State of New York,
         without regard to the conflict of laws provisions thereof. Any
         litigation relating to this Agreement will be brought in a U.S. federal
         court if there is jurisdiction. The parties waive the right to trial by
         jury in any matter which arises under this Agreement.

                                       12
<PAGE>

9.14     Any rights and obligations which by their nature survive and continue
         after any expiration or termination of this Agreement will survive and
         continue and will bind the parties and their successors and permitted
         assigns, until such obligations are fulfilled.

9.15     This Agreement and the Appendix are the complete and exclusive
         agreement between the parties regarding the subject matter hereof and
         supersede any prior oral or written communications or understandings
         between the parties related to the subject matter hereof.

By signing below, the parties agree to the terms of this Agreement.

INTERNATIONAL BUSINESS                        TURBOWORX, INC.
MACHINES CORPORATION

------------------------------                ------------------------------
Leigh Cagan                                   Andrew Sherman
Manager, Business Development                 Vice President, Operations

Date:                                         Date:
     -------------------------                     -------------------------

                                       13
<PAGE>

                                   APPENDIX A

"Licensed Software" includes the following:

TSpaces version 3.0

                                       14EXHIBIT 10.13

"THE  SECURITIES  REPRESENTED  BY  THIS  CERTIFICATE  (I)  ARE  SUBJECT  TO  THE
RESTRICTIONS ON TRANSFER AND OTHER TERMS  CONTAINED IN A SUBSCRIPTION  AGREEMENT
DATED MARCH 11, 2003, BETWEEN THE COMPANY AND THE HOLDER OF THIS WARRANT (A COPY
OF WHICH IS AVAILABLE  WITHOUT CHARGE FROM THE COMPANY),  AND (II) HAVE NOT BEEN
REGISTERED  UNDER THE SECURITIES ACT OF 1933 OR APPLICABLE STATE SECURITIES LAWS
AND MAY NOT BE TRANSFERRED,  SOLD OR OTHERWISE  DISPOSED OF IN THE ABSENCE OF AN
EFFECTIVE  REGISTRATION  STATEMENT WITH RESPECT TO THE  SECURITIES  EVIDENCED BY
THIS CERTIFICATE,  FILED AND MADE EFFECTIVE UNDER THE SECURITIES ACT OF 1933 AND
SUCH APPLICABLE STATE SECURITIES LAWS, OR UNLESS THE COMPANY RECEIVES AN OPINION
OF COUNSEL  SATISFACTORY  TO THE COMPANY TO THE EFFECT THAT  REGISTRATION  UNDER
SUCH ACT AND SUCH APPLICABLE STATE SECURITIES LAWS IS NOT REQUIRED."

                                 TURBOWORX, INC.

                                    No. SCA-l

                      WARRANT TO SUBSCRIBE FOR COMMON STOCK

                               STOCK SUBSCRIPTION

                                     WARRANT

                                  MARCH 11,2003

                         Not Transferable or Exercisable
                     Except Upon Conditions Herein Specified

         THIS  CERTIFIES   that  for  value   received,   Scientific   Computing
Associates,  Inc.  (the  "Subscriber"),  a  corporation  with an  address at One
Century Tower, 265 Church Street,  New Haven,  Connecticut 06510, is entitled to
subscribe for and purchase from  TURBOWORX,  INC., a Delaware  corporation  (the
"Company"),  that number of shares of Common Stock, $.001 par value per share of
the Company as is  determined  in  accordance  with  Section 1 hereof  ("Warrant
Stock"),  at the exercise  price per share  determined  as provided in Section 1
hereof (such price from time to subject to adjustment in accordance with Section
4 hereof and hereinafter  called the "Warrant Price"),  at any time or from time
to time during the applicable period set forth in Section 1 hereof.

         This  Warrant is issued  pursuant  to, and is subject to, that  certain
Subscription  Agreement,  dated as of March II, 2003, by and between the Company
and  the  Subscriber  (the  "Subscription  by the  legal  holder  hereof  at the
principal office of the Company.  Capitalized terms not otherwise defined herein
shall have the meanings set forth in the Subscription Agreement.

         SECTION 1. Calculation of Warrant Stock; Exercise Price; Term.

<PAGE>

         (a)  Except  as  otherwise  provided  herein,  the  number of shares of
Warrant Stock and the term of exercise shall be calculated as provided below:

                  (i) At the end of the  first  calendar  quarter  during  which
gross revenues to the Company (as calculated from the date of incorporation,  in
accordance with generally accepted accounting principles,  "Gross Revenues") are
equal to or greater than $10,000,000, this Warrant shall be exercisable for that
number of shares of Warrant  Stock as equals one percent  (1%) of the issued and
outstanding  shares  of  Common  Stock  of the  Company  as of  such  time.  The
Subscriber may exercise this Warrant to purchase any Warrant Stock available for
exercise  pursuant  to this  Section  l(a)(i)  at any time or from  time to time
during the period from the date of calculation thereof to the date that is seven
(7) years thereafter.

                  (ii) At the end of the first  calendar  quarter  during  which
Gross Revenues are equal to or greater than  $20,000,000,  this Warrant shall be
exercisable for that number of shares of Warrant Stock which,  when added to the
amount of Warrant Stock set forth in Section 1 (a)(i) above, if any, shall equal
two percent  (2%) of the issued and  outstanding  shares of Common  Stock of the
Company as of such time.  The  Subscriber  may exercise this Warrant to purchase
any  additional  Warrant Stock  available for exercise  pursuant  solely to this
Section  l(a)(ii)  at any time or from time to time  during the period  from the
date of calculation thereof to the date that is seven (7) years thereafter.

                  (iii) At the end of the first  calendar  quarter  during which
Gross Revenues are equal to or greater than  $30,000,000,  this Warrant shall be
exercisable for that number of shares of Warrant Stock which,  when added to the
amount of Warrant  Stock set forth in Sections  1(a)(1) and l(a)(ii)  above,  if
any,  shall equal three  percent  (3%) of the issued and  outstanding  shares of
Common Stock of the Company as of such time.  The  Subscriber  may exercise this
Warrant to purchase any additional Warrant Stock available for exercise pursuant
solely to this  Section  1(a)(iii)  at any time or from time to time  during the
period from the date of calculation  thereof to the date that is seven (7) years
thereafter.

                  (iv) At the end of the first  calendar  quarter  during  which
Gross Revenues are equal to or greater than  $40,000,000,  this Warrant shall be
exercisable for that number of shares of Warrant Stock which,  when added to the
amount of Warrant Stock set forth in Sections  l(a)(i) through 1 (a)(iii) above,
if any,  shall equal four percent (4%) of the issued and  outstanding  shares of
Common Stock of the Company as of such time.  The  Subscriber  may exercise this
Warrant to purchase any additional Warrant Stock available for exercise pursuant
solely to this  Section  l(a)(iv)  at any time or from time to time  during  the
period from the date of calculation  thereof to the date that is seven (7) years
thereafter.

                  (v) At the end of the  first  calendar  quarter  during  which
Gross Revenues are equal to or greater than  $50,000,000,  this Warrant shall be
exercisable for that number of shares of Warrant Stock which,  when added to the
amount of Warrant Stock set forth in Sections  l(a)(i)  through 1 (a)(iv) above,
if any,  shall equal five percent (5%) of the issued and  outstanding  shares of
Common Stock of the Company as of such time,  The  Subscriber  may exercise this
Warrant to purchase any additional Warrant Stock available for exercise pursuant
solely to this  Section I (a)(v)  at any time or from  time to time  during  the
period from the date of calculation  thereof to the date that is seven (7) years
thereafter.

<PAGE>

                  (vi) At the end of the first  calendar  quarter  during  which
Gross Revenues are equal to or greater than  $60,000,000,  this Warrant shall be
exercisable for that number of shares of Warrant Stock which,  when added to the
amount of Warrant  Stock set forth in Sections 1 (a)(i)  through 1 (a)(v) above,
if any,  shall equal six percent  (6%) of the issued and  outstanding  shares of
Common Stock of the Company as of such time.  The  Subscriber  may exercise this
Warrant to purchase any additional Warrant Stock available for exercise pursuant
solely to this  Section 1 (a)(vi)  at any time or from time to time  during  the
period from the date of calculation  thereof to the date that is seven (7) years
thereafter.

                  (vii) At the end of the first  calendar  quarter  during which
Gross Revenues are equal to or greater than  $70,000,000,  this Warrant shall be
exercisable for that number of shares of Warrant Stock which,  when added to the
amount of Warrant Stock set forth in Sections 1 (a)(i) through  1(a)(vi)  above,
if any, shall equal seven percent (7%) of the issued and  outstanding  shares of
Common Stock of the Company as of such time.  The  Subscriber  may exercise this
Warrant to purchase any additional Warrant Stock available for exercise pursuant
solely to this  Section 1 (a)(vii)  at any time or from time to time  during the
period from the date of calculation  thereof to the date that is seven (7) years
thereafter.

                  (viii) At the end of the first  calendar  quarter during which
Gross Revenues are equal to or greater than  $80,000,000,  this Warrant shall be
exercisable for that number of shares of Warrant Stock which,  when added to the
amount of Warrant Stock set forth in Sections  l(a)(i) through 1 (a)(vii) above,
if any, shall equal eight percent (8%) of the issued and  outstanding  shares of
Common Stock of the Company as of such time.  The  Subscriber  may exercise this
Warrant to purchase any additional Warrant Stock available for exercise pursuant
solely to this  Section 1 (a)(viii)  at any time or from time to time during the
period from the date of calculation  thereof to the date that is seven (7) years
thereafter.

                  (ix) At the end of the first  calendar  quarter  during  which
Gross Revenues are equal to or greater than  $90,000,000,  this Warrant shall be
exercisable for that number of shares of Warrant Stock which,  when added to the
amount of Warrant Stock set forth in Sections 1 (a)(i) through l(a)(viii) above,
if any,  shall equal nine percent (9%) of the issued and  outstanding  shares of
Common Stock of the Company as of such time.  The  Subscriber  may exercise this
Warrant to purchase any additional Warrant Stock available for exercise pursuant
solely to this Section  l(ix) at any time or from time to time during the period
from the  date of  calculation  thereof  to the date  that is  seven  (7)  years
thereafter.

                  (x) At the end of the  first  calendar  quarter  during  which
Gross Revenues are equal to or greater than $100,000,000,  this Warrant shall be
exercisable for that number of shares of Warrant Stock which,  when added to the
amount of Warrant Stock set forth in Sections  l(a)(i)  through I (a)(ix) above,
if any,  shall equal ten percent (10%) of the issued and  outstanding  shares of
Common Stock of the Company as of such time.  The  Subscriber  may exercise this
Warrant to purchase any additional Warrant Stock available for exercise pursuant
solely to this  Section  1(j) at any time or from time to time during the period
from the  date of  calculation  thereof  to the date  that is  seven  (7)  years
thereafter.

         (b) Notwithstanding  anything herein to the contrary, in the event that
that certain License  Agreement,  dated as of March 11, 2003, by and between the
Company and the

<PAGE>

undersigned  (the "License  Agreement") is terminated by the  undersigned,  this
Warrant shall be exercisable  only for the number of shares of Warrant Stock, if
any,  calculated  in  accordance  with  Section  1(a)  hereof,  for any  revenue
milestones  achieved  prior to the effective  date of termination of the License
Agreement.

         (c) Notwithstanding  anything herein to the contrary, in the event that
the License  Agreement is terminated by the Company  pursuant to Section  9.2(d)
thereof,  the Warrant  Stock and the term of exercise of this  Warrant  shall be
calculated as provided below:

                  (i) This Warrant  shall be  immediately  exercisable  for that
number of shares of Warrant  Stock as equals one percent  (1%) of the issued and
outstanding  shares of Common Stock of the Company as of the  effective  date of
such  termination  and the undersigned may exercise this Warrant to purchase any
Warrant  Stock  available for exercise  pursuant to this Section  l(c)(i) at any
time or  from  time to  time  during  the  period  from  the  effective  date of
termination  of the  License  Agreement  to the  date  that is seven  (7)  years
thereafter.

                  (ii) Each of the  percentages  of stock  set forth in  Section
1(a)(i) through 1(a)(ix) shall be increased by one percent (1%),  except that no
shares of Warrant  Stock  shall  issue  based upon  Gross  Revenues  equal to or
greater  than  two  times  the  Gross  Revenues  as of  the  effective  date  of
termination of the License Agreement plus $5,000,000.

         (d) Notwithstanding  anything herein to the contrary, in the event that
at any time during  which the License  Agreement  is in effect:  (i) a Change of
Control (as hereinafter defined) is effected;  or (ii) the Company consummates a
Qualified IPO (as  hereinafter  defined),  the number of shares of Warrant Stock
for which this  warrant  may be  exercised  shall equal that number of shares of
Warrant  Stock which,  when added to the amounts of Warrant Stock for which this
Warrant could be exercised  prior to such date,  equals ten percent (10%) of the
issued and  outstanding  Common  Stock of the Company  immediately  prior to the
effective date of such event. For purposes hereof:

         "Change of  Control"  shall mean (i) a  consolidation  or merger of the
Company  with or into any other  entity or any  other  transaction  in which the
holders  of  the   Company's   outstanding   shares   immediately   before  such
consolidation,  merger  or other  transaction  do not,  immediately  after  such
consolidation,  merger  or other  transaction,  retain  stock  or  other  equity
interests representing a majority of the voting power of the surviving entity of
such consolidation or merger; or (ii) a sale, lease,  exclusive license or other
disposition of all or substantially  all of the assets or intellectual  property
of the Company.

         "Qualified   IPO"  shall  mean  the   closing  of  a  firm   commitment
underwritten  public offering  pursuant to an effective  registration  statement
filed under the Securities Act of 1933, as amended,  covering the offer and sale
of Common  Stock for the  account  of the  Company  in which the  aggregate  net
proceeds of such public offering (after deduction of underwriters' discounts and
commissions) equals or exceeds $15,000,000 and where the pre-money equity market
capitalization of the Corporation equals or exceeds $90,000,000.

         (e) The Warrant Price for the Warrant Stock as calculated in accordance
with Sections 1(a), 1 (b), 1(c) or 1(d) above,  as  applicable,  shall equal the
exercise  price  applicable to

<PAGE>

the most recent option for the Company's Common Stock granted to any employee or
consultant  of the Company  prior to the time of the  applicable  Warrant  Stock
calculation.

         (f) The Company  shall,  within ten (10) days of receipt of any written
request  by the  Subscriber  therefor,  provide  to  the  Subscriber  a  writing
evidencing: (i) the number of shares of Warrant Stock for which this Warrant may
be  exercised  as of the  date of such  writing;  and  (ii)  the  Warrant  Price
applicable thereto.

         SECTION 2. EXERCISE OF WARRANT.  The rights represented by this Warrant
may be exercised by the holder  hereof in whole at any time or in part from time
to time during the applicable term set forth in Section 1 hereof,  but not as to
a fractional share of Warrant Stock, by the surrender of this Warrant  (properly
endorsed) at the office of the Company, at One Century Tower, 265 Church Street,
New Haven,  Connecticut  06510 (or at such other agency or office of the Company
in the United  States of America as it may designate by notice in writing to the
holder  hereof  at the  address  of such  holder  appearing  on the books of the
Company),  and by payment  to the  Company  of the  Warrant  Price in cash or by
certified or cashier's check or wire transfer for each share being purchased.

         Notwithstanding  anything herein to the contrary, in lieu of exercising
this  Warrant as  hereinabove  permitted,  the  Subscriber  may elect to receive
shares of Warrant Stock equal to the value (as determined below) of this Warrant
(or the portion  thereof  being  canceled)  by  surrender of this Warrant at the
principal   office  of  the  Company,   together  with  the  properly   endorsed
Subscription Form, in which event the Company shall issue to the Subscriber that
number of shares of Warrant Stock computed using the following formula:

                               SAS = WS x (CP-EP)
                               ------------------
                                       CP

Where:

         SAS      equals the  number of shares of Warrant  Stock to be issued to
                  the Subscriber;  and

         WS       equals the number of shares of Warrant Stock purchasable under
                  the  Warrant  or, if only a portion  of the  Warrant  is being
                  exercised,  the portion of the Warrant being exercised (at the
                  date of such calculation); and

         CP       equals the Closing  Price (as  hereinafter  defined) as of the
                  date of exercise.  "Closing  Price" on any day shall mean,  in
                  the absence of an established  market for the Company's Common
                  Stock,  the valuation per share as determined in good faith by
                  the Board of Directors;  provided,  however,  that where there
                  exists a public  market  for the  Common  Stock at the time of
                  such  exercise,  the Closing Price per share shall be equal to
                  the average of the closing bid and asked  prices of the Common
                  Stock  quoted in the  Over-The-Counter  Market  Summary or the
                  last  reported  sale price of the Common  Stock or the closing
                  price quoted on the NASDAQ  National  Market  System or on any
                  exchange  on which the Common  Stock is listed,  whichever  is
                  applicable,  as published  in The Wall Street  Journal for the
                  five

<PAGE>

                  (5)  trading  days prior to the date of  determination  of the
                  Closing Price. Notwithstanding the foregoing, in the event the
                  Warrant is exercised in connection with the Company's  initial
                  public  offering of Common Stock,  the Closing Price per share
                  shall be equal to the per share  offering  price to the public
                  of the Common Stock issued in the initial public offering; and

         EP       equals  the  per  share   exercise  price  (as  calculated  in
                  accordance with Section 1 hereof).

         In the event of any exercise of the rights represented by this Warrant,
a  certificate  or  certificates  for the shares of Warrant  Stock so purchased,
registered  in the name of the holder,  shall be delivered to the holder  hereof
within a reasonable time, not exceeding  twenty-five (25) days, after the rights
represented  by this  Warrant  shall have been so  exercised;  and,  unless this
Warrant  has  expired,  a new Warrant of like tenor  representing  the number of
shares,  if any,  with  respect to which this  Warrant  shall not then have been
exercised shall also be issued to the holder hereof within such time. The person
in whose  name any  certificate  for  shares of  Warrant  Stock is  issued  upon
exercise  of this  Warrant  shall for all  purposes be deemed to have become the
holder of record of such shares on the date on which the Warrant was surrendered
and payment of the Warrant Price and any applicable taxes was made, irrespective
of the date of delivery of such  certificate,  except that,  if the date of such
surrender and payment is a date when the stock transfer books of the Company are
closed,  such person shall be deemed to have become the holder of such shares at
the close of business on the next  succeeding  date on which the stock  transfer
books are open.  The Company shall pay any issue tax imposed on exercise of this
Warrant for Warrant  Stock,  provided,  however,  that the  Subscriber  shall be
required  to pay any and all  taxes  which  may be  payable  in  respect  of any
transfer  involved in the  issuance and  delivery of any  certificate  in a name
other than that of the Subscriber as reflected upon the books of the Company.

         Notwithstanding  the foregoing or anything to the contrary herein, this
Warrant  may  be  exercised  only  upon  the  delivery  to  the  Company  of any
certificates,  legal opinions,  or other documents  reasonably  requested by the
Company or its counsel to satisfy the Company and its counsel  that the proposed
exercise  of  this  Warrant  may be  effected  without  registration  under  the
Securities Act of 1933, as amended. The Holder shall not be entitled to exercise
this  Warrant,  or any part hereof,  unless and until such  certificates,  legal
opinions or other  documents  are  reasonably  acceptable to the Company and its
counsel.

         SECTION 3.  COVENANTS AS TO WARRANT  STOCK.  The Company  covenants and
agrees that all shares of Warrant  Stock that may be issued upon the exercise of
the rights  represented by this Warrant will, upon issuance,  be validly issued,
fully paid and  nonassessable,  and free from all taxes,  liens and charges with
respect to the issue thereof.  The Company further covenants and agrees that the
Company will at all times have  authorized  and reserved,  free from  preemptive
rights,  a sufficient  number of shares of its Warrant  Stock to provide for the
exercise  of the  rights  represented  by  this  Warrant.  The  Company  further
covenants  and agrees that if any shares of capital stock to be reserved for the
purpose of the  issuance of shares upon the  exercise  of this  Warrant  require
registration with or approval of any governmental authority under any Federal or
State law before such shares may be validly  issued or delivered  upon exercise,
then the Company will in good faith and as expeditiously as possible endeavor to
secure such registration or

<PAGE>

approval,  as the case may be. If and so long as the Warrant Stock issuable upon
the exercise of this Warrant is listed on any national securities exchange,  the
Company will, if permitted by the rules of such  exchange,  list and keep listed
on such exchange,  upon official notice of issuance,  all shares of such Warrant
Stock issuable upon exercise of this Warrant.

         SECTION 4. ADJUSTMENT OF NUMBER OF SHARES.  Upon each adjustment of the
Warrant  Price as  provided  in  Section  5, the  holder of this  Warrant  shall
thereafter  be entitled to purchase,  at the Warrant Price  resulting  from such
adjustment,  the number of shares  (calculated  to the nearest tenth of a share)
obtained by multiplying  the Warrant Price in effect  immediately  prior to such
adjustment by the number of shares purchasable pursuant hereto immediately prior
to such  adjustment  and  dividing  the  product  thereof by the  Warrant  Price
resulting from such adjustment.

         SECTION 5.  ADJUSTMENT  OF WARRANT  PRICE.  The  Warrant  Price and the
securities  purchasable  upon  exercise  of this  Warrant  shall be  subject  to
adjustment from time to time as follows:

                  (i) If, at any time during the Term of this  Warrant but after
a  calculation  of Warrant  Stock,  the number of shares of Common  Stock of the
Company outstanding is increased by a stock dividend payable in shares of Common
Stock or by a subdivision or split-up of shares of Common Stock, then, following
the record date fixed for the  determination of holders of Common Stock entitled
to receive such stock dividend, subdivision or split-up, the Warrant Price shall
be  appropriately  decreased  so that the  number  of shares  of  Warrant  Stock
issuable  upon the exercise  hereof shall be  increased  in  proportion  to such
increase in outstanding shares.

PAGE 8 MISSING

                  (ii) In any case in which  the  provision  of this  Section  5
shall  require that an adjustment  shall become  effective  immediately  after a
record date for an event,  the Company  may defer until the  occurrence  of such
event  issuing  to the  holder  of all or any  part of  this  Warrant  which  is
exercised  after such  record date and before the  occurrence  of such event the
additional  shares of capital stock issuable upon such exercise by reason of the
adjustment  required  by such event  over and above the shares of capital  stock
issuable upon such exercise  before giving effect to such  adjustment  exercise;
provided,  however,  that the Company shall deliver to such holder a due bill or
other  appropriate  instrument  evidencing  such holder's  right to receive such
additional shares upon the occurrence of the event requiring such adjustment.

                  (iii)  The  sale or other  disposition  of any  Warrant  Stock
theretofore  held in the  treasury  of the  Company  shall  be  deemed  to be an
issuance thereof.

         SECTION 6. STOCKHOLDER RIGHTS.  Except as specifically  provided for in
this  Warrant,  this Warrant  shall not entitle the holder  hereof to any voting
rights or other rights as a  stockholder  of the Company.  Upon exercise of this
Warrant and at the request of the Company,  the holder  hereof  shall  execute a
joinder  agreement  whereby  it will  become  a party to such  other  agreements
between the Company and its shareholders as may be in effect at such time.

         SECTION  7.  TRANSFER  OF  WARRANT.  Subject to the  provisions  of the
Subscription Agreement,  this Warrant and all rights hereunder are transferable,
in whole or in part, but only upon surrender of this Warrant properly  endorsed.
Each taker and holder of this Warrant,  by

<PAGE>

taking or  holding  the same,  consents  and  agrees  that  this  Warrant,  when
endorsed, in blank, shall be deemed negotiable,  and when so endorsed the holder
hereof may be treated by the Company  and all other  persons  dealing  with this
Warrant as the absolute owner hereof for any purposes and as the person entitled
to exercise the rights represented by this Warrant, or to the transfer hereof on
the books of the Company, any notice to the contrary notwithstanding;  but until
such transfer on such books, the Company may treat the registered  holder hereof
as the owner hereof for all purposes.

         SECTION 8.  EXCHANGE OF WARRANT.  This  Warrant is  exchangeable,  upon
surrender  hereof by the holder  hereof at the  office or agency of the  Company
designated in Section 2 hereof,  for new Warrants of like tenor  representing in
the aggregate the right to subscribe for and purchase the number of shares which
may be  subscribed  for and  purchased  hereunder,  each of such new Warrants to
represent the right to subscribe for and purchase such number of shares as shall
be designated by said holder hereof at the time of such surrender.

         SECTION  9. LOST,  STOLEN,  MUTILATED  OR  DESTROYED  WARRANT.  If this
Warrant is lost, stolen,  mutilated or destroyed, the Company may, on such terms
as to indemnity or otherwise as it may in its discretion impose (which shall, in
the case of a mutilated  Warrant,  include the surrender  thereof),  issue a new
Warrant of like denomination and tenor as the Warrant so lost, stolen, mutilated
or  destroyed.  Any such new Warrant shall  constitute  an original  contractual
obligation of the Company,  whether or not the allegedly lost, stolen, mutilated
or destroyed Warrant shall be at any time enforceable by anyone.

         SECTION 10.  FRACTIONAL  SHARES.  Fractional shares shall not be issued
upon the exercise of this Warrant,  but in any case where the Subscriber  would,
except for the provisions of this Section 10, be entitled under the terms hereof
to receive a fractional  share upon the complete  exercise of this Warrant,  the
Company shall, upon the exercise of this Warrant for the largest number of whole
shares then called for,  cancel this  Warrant and pay a sum in cash equal to the
value of such fractional share  (determined in such reasonable  manner as may be
prescribed in good faith by the Board of Directors of the Company).

         SECTION 11.  INFORMATION RIGHTS.

         (a) The  Subscriber  shall  furnish  to the  Company  such  information
regarding such  Subscriber as the Company may reasonably  request in writing and
as  shall  be  reasonably   required  in  connection   with  any   registration,
qualification or compliance.

         (b) The Company shall furnish to the Subscriber:

                  (i) as soon as  practicable  after the end of each fiscal year
of the Company  during  which this  Warrant may be  exercised,  and in any event
within ninety (90) days  thereafter,  a balance sheet of the Company,  as at the
end of such fiscal year, and a statement of income and a statement of cash flows
of the  Company,  for such year,  all  prepared  in  accordance  with  generally
accepted accounting  principles  consistently  applied and setting forth in each
case in  comparative  form the  figures for the  previous  fiscal  year,  all in
reasonable  detail,  together with management's  discussion and analysis of such
statements; and

<PAGE>

                  (ii) at the same time and in the same manner as it is provided
to the  stockholders  of the  Company,  a copy of any  notice,  consent or other
communication distributed by the Company to its stockholders as stockholders.

         (c) To the extent not otherwise provided herein, in the event of:

                  (i) any taking by the  Company  of a record of the  holders of
any class of securities for the purpose of determining  the holders  thereof who
are  entitled to receive any  dividend  or other  distribution,  or any right to
subscribe for, purchase or otherwise acquire any shares of stock of any class or
any other securities or property, or to receive any other right, or

                  (ii)  any  capital   reorganization   of  the   Company,   any
reclassification or recapitalization of the capital stock of the Company, or any
transfer  of  all  or  substantially  all  the  assets  of  the  Company  to  or
consolidation or merger of the Company with or into any other person, or

                  (iii) any Change of Control, or Company,

then and in each such event the Company will promptly mail or cause to be mailed
to the holder of this Warrant a notice specifying (i) the date on which any such
record is to be taken for the purpose of such dividend,  distribution  or right,
and stating the amount and character of such  dividend,  distribution  or right,
and  (ii)  the  date  on  which  any  such   reorganization,   reclassification,
recapitalization,   transfer,   consolidation,   merger,   Change  of   Control,
dissolution,  liquidation  or winding-up is to take place.  Such notice shall be
mailed at least  five (5) days  prior to the date  specified  in such  notice on
which any such action is to be taken.

         SECTION 12. LAW  GOVERNING.  This  Warrant  shall be  governed  by, and
construed  and enforced in accordance  with,  the laws of the State of Delaware,
without giving effect to the principles of conflicts of law thereof.

         SECTION 13.  MISCELLANEOUS.

         (a) This  Warrant  and any  provision  hereof may be  changed,  waived,
discharged  or terminated  only by an instrument in writing  signed by the party
(or any predecessor in interest  thereof) against which  enforcement of the same
is sought.  The headings in this Warrant are for purposes of reference  only and
shall not affect the meaning or construction of any of the provisions hereof.

         (b) Any provision of this Warrant which is prohibited or  unenforceable
in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent
of such  prohibition  or  unenforceability  without  invalidating  the remaining
provisions  hereof,  and  any  such  prohibition  or   unenforceability  in  any
jurisdiction shall not invalidate or render  unenforceable such provision in any
other jurisdiction.

         (c)  The  Company  will  not,  by  amendment  of  its   Certificate  of
Incorporation or through any reorganization,  transfer of assets, consolidation,
merger, dissolution,  issue or sale of securities or any other voluntary action,
avoid or seek to avoid the observance or performance of any of the terms of this
Warrant,  but will at all times in good faith  assist in the carrying out of all

<PAGE>

such  terms  and in the  taking  of  all  such  action  as may be  necessary  or
appropriate  in order to  protect  the  rights of the  holder  of this  Warrant.
Without  limiting  the  generality  of the  foregoing,  the Company (i) will not
increase the par value of any shares of stock  receivable on the exercise of the
Warrant above the amount payable  therefor on such exercise,  and (ii) will take
all such action as may be necessary or appropriate in order that the Company may
validly and legally  issue fully paid and  nonassessable  shares of stock on the
exercise of this Warrant from time to time outstanding.

                            [SIGNATURE PA GE FOLLOWS]

<PAGE>

         IN WITNESS  WHEREOF,  TURBOWORX,  INC.  has caused  this  Warrant to be
executed by its duly authorized officer,  and this Warrant to be dated March 11,
2003.

                                             TURBOWORX, INC.

                                             By:
                                                --------------------------------
                                             Name:  Jeffrey Augen
                                             Title: President

ATTEST:

--------------------------------
Name:

<PAGE>

                              FORM OF SUBSCRIPTION

                  [To be signed only upon exercise of Warrant[

To:      TURBOWORX, INC.

         The undersigned,  the holder of the within Warrant,  hereby irrevocably
elects to exercise the purchase  right  represented  by such Warrant for, and to
purchase thereunder, _____________ shares of Common Stock of TURBOWORX, INC. and
herewith  makes  payment of  $________________  therefor,  and requests that the
certificates  for such  shares  be  issued  in the name of,  and  delivered  to,
______________ , whose address is

Dated:
      -----------------------

By:
   --------------------------
     (Signature)

-----------------------------

-----------------------------
     (Address)

<PAGE>

                               FORM OF ASSIGNMENT

                  [To be signed only upon exercise of Warrant[

         For value received, the undersigned hereby sells, assigns and transfers
unto  _______________________  the right  represented  by the within  Warrant to
purchase  _______ shares of Common Stock of TURBOWORX,  INC. to which the within
Warrant relates, and appoints  ___________________,  Attorney,  to transfer such
right on the books of  TURBOWORX,  INC. with full power of  substitution  in the
premises.

Dated:
      -----------------------

By:
   --------------------------
     (Signature)

-----------------------------

-----------------------------
     (Address)

Signed in the Presence of:

-----------------------------

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00085-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00085-of-00352.parquet"}]]